Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Nephrology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A more accurate method acquirement by a comparison of the prediction equations for estimating glomerular filtration rate in Chinese patients with obstructive nephropathy

  • Meixue Chen1,
  • Jumei Xia1,
  • Guangchang Pei1,
  • Ying Zhang1,
  • Shuting Wu2,
  • Yushuang Qin2,
  • Yuanjun Deng1,
  • Shuiming Guo1,
  • Yanyan Guo1,
  • Gang Xu1Email author and
  • Min Han1Email author
BMC NephrologyBMC series – open, inclusive and trusted201617:150

https://doi.org/10.1186/s12882-016-0345-0

Received: 28 June 2015

Accepted: 5 September 2016

Published: 18 October 2016

Abstract

Background

Researchers have developed several equations to predict glomerular filtration rate (GFR) in patients with chronic kidney diseases (CKD). However, there are scarcely any studies performed to discern the best equation to estimate GFR in patients with pure obstructive nephropathy. In present study, we assessed the suitability of six prediction equations and compared their performance in eGFR evaluation for Chinese patients with obstructive nephropathy.

Methods

A total of 245 adult patients with obstructive nephropathy were enrolled. We evaluated the performance of the 3 Modification of Diet in Renal Disease equations (MDRD) (the original MDRD7, 7MDRD; the abbreviated MDRD, aMDRD; and re-expressed abbreviated MDRD, re-aMDRD) and 3 Chronic Kidney Disease Epidemiology Collaboration equations (CKD-EPI) (CKD-EPI equation based on creatinine alone, CKD-EPIcr; CKD-EPI equation based on cystatin C alone, CKD-EPIcys; CKD-EPI equation based on combined creatinine-cystatin, CKD-EPIcr-cys). The measured GFR (mGFR) by 99mTc-DTPA renal dynamic imaging method was used as the reference GFR.

Results

The mean age of the study population was 51.61 ± 14.17 and 131 were male (53.47 %). The mean measured GFR was 66.54 ± 23.99 ml/min/1.73 m2. Overall, the CKD-EPIcr-cys equation gave the best performance with the best correlation (R = 0.72) and agreement (−34.87, 40.83). CKD-EPIcr-cys equation also exhibited the highest accuracy (69.39 %, P < 0.01) and diagnostic efficacy (ROCAUC = 0.874) with the smallest bias (2.98, P < 0.01). In the subgroup of the lowest GFR, CKD-EPIcys equation exhibited the highest accuracy (52.69 %) and the smallest bias (0.27). In the youngest age subgroup, CKD-EPIcys equation had the highest accuracy (71.64 %) and the smallest bias (−1.24). In other subgroups stratified by GFR, age and gender, CKD-EPIcr-cys equation remained the best performance.

Conclusion

The 3 CKD-EPI equations performed better than the 3 MDRD equations in estimating GFR in Chinese obstructive nephropathy patients; while the CKD-EPI equation based on combined creatinine-cystatin C provided the best estimation of GFR.

Keywords

Obstructive nephropathyeGFR equationGlomerular filtration rate

Background

Glomerular filtration rate (GFR) is an important indicator of the filtering capacity of kidneys and is considered the best overall index of renal function currently used [1]. Estimated glomerular filtration rate (eGFR) is the most important variable in the assessment of patients with suspected or known kidney disease in clinical practice [2]. Traditional methods using renal clearances of exogenous inulin, or other alternative exogenous markers (such as iothalamate, EDTA, diethylene triamine pentaacetic acid, and iohexol) can provide accurate GFR evaluation [3]. However, these tests are time consuming and expensive [4], which limits the application to monitor kidney function periodically. As an alternative, GFR estimating equations have been recommended in clinical practice. In 1976, the first creatinine clearance estimating equation - Cockcroft-Gault equation was developed [5]. From then on, researchers have developed and calibrated a series of equations to provide convenient, time-saving and reproducible estimation of kidney function, such as MDRD (Modification of Diet in Renal Disease) and CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations etc. [69]. Recently, the CKD-EPI group have developed new equations based on serum cystatin C and combined creatinine-cystatin C, which were shown to perform better than the previous CKD-EPI equation based on serum creatinine alone [10]. However, the new equations have not been externally validated in a Chinese population yet. Obstructive nephropathy refers to the renal disease caused by impaired urine flow or tubular fluid [11], which is taken as one of the most common reasons for chronic kidney disease (CKD) [1214]. It can be caused by stone, tumor, prostatic hyperplasia, etc. Long-term urinary tract obstruction can lead to renal fibrosis [15]. The pathological process of obstructive nephropathy is different from diffuse renal diseases initiated by immune mechanism, in which the damage of both kidneys are almost the same. However, obstructive nephropathy often occurs unilaterally. Even if it happens bilaterally, the degree of renal damage in the left and right kidneys is not equal. The effects of urinary tract obstruction on renal function must be considered both during and after relief of obstruction and are greatly influenced by whether the obstruction is unilateral or bilateral,acute or chronic, partial or complete [14]. To the best of our knowledge, no studies have validated these eGFR equations only in obstructive nephropathy patients. The current study aimed at testing and comparing the estimations of 6 commonly used eGFR equations (3 MDRD equations and 3 CKD-EPI equations), including the new developed CKD-EPI equation based on combined creatinine-cystatin C [10] in pure obstructive nephropathy patients.

Methods

Patients

This study was performed as a retrospective study using resident patients diagnosed with obstructive nephropathy who had underwent a GFR measurement by 99mTc-diethylenetriamine penta-acetate (99mTc-DTPA) in Tongji Hospital of Huazhong University of Science and Technology (Wuhan, China) between May, 2012, and October, 2013. To be included, the age had to be at least 18 years; the biochemical results, body weight, and height had to be available from the patients’ case records within 3 months of the GFR measurement. For patients who had more than one GFR measurements, the first one was used for analysis. Patients with acute kidney injury, severe edema, pleural effusion or ascites, malnutrition, amputation or skeletal muscle atrophy, heart failure or ketoacidosis were excluded. Patients who were taking cimetidine, trimethoprim or those who were on any kind of renal replacement therapy were also excluded [16]. Finally, a total of 245 individuals were enrolled in the present study.

GFR measurements

The measurement of GFR was performed using 99mTc-DTPA renal dynamic imaging by Ifinia Hawkeye 4 SPECT (GE Healthcare, USA). The identical standard measuring method was as follows: patients were hydrated with 300 ml of water 30mins before the examination. Radioactivity of the syringe containing 99mTc-DTPA (provided by Jiangsu Atom Medicine Research Institute, Jiangyuan Pharmaceutical Factory) was counted before injection. And then each of the patients was given a bolus of intravenous injection of approximately 185 MBq DTPA into the forearm. After that, the dynamic renal flow images were collected immediately using the XelerisTM3 Functional Imaging Workstation (GE Healthcare Biosciences, Piscataway, NJ, USA). The post-injection syringe was also counted. Thus the difference of the syringe’s radioactivity between pre- and post-injection was defined as the exact dosage of administered 99mTc-DTPA. The calculation of GFR values was done by the XelerisTM3 Functional Imaging Workstation automatically according to the modified Gate’s equation [17, 18]. The measured GFR (mGFR) was standardized by body surface area (BSA) [15].

Biochemical measurements

Serum creatinine was measured by Roche enzymatic assay (Shanghai Roche Diagnostic Products Co., Ltd, China). Cystatin C was determined by article-enhanced immunoturbidimetry assay (Beijing Leadman Biomedical Co., Ltd, China). All of the fasting blood samples were assayed on a Roche automatic biochemical analyser (cobas 8000 modular analyzer series, Roche Diagnostics Operations, Inc, USA). For patients who had multiple check results, the one nearest date of GFR measurement was used.

Estimation of GFR

Estimated GFR (eGFR) were calculated by 6 different equations; including 3 MDRD equations (the original MDRD7 [6], the abbreviated MDRD equation [7] and the reexpressed abbreviated MDRD [8] equation, hereafter referred to as the 7MDRD equation, aMDRD equation and re-aMDRD equation respectively); and 3 CKD-EPI equations (CKD-EPI equation based on creatinine alone [9], CKD-EPI equation based on cystatin C alone, and CKD-EPI equation based on combined creatinine-cystatin C [10], hereafter referred to as the CKD-EPIcr equation, CKD-EPIcys equation, and CKD-EPIcr-cys equation respectively). All the equations were all listed in Table 1.
Table 1

Equations to estimated GFR

eGFR method

Equation

7MDRD

170 × (Scr)-0.999 × (Age)-0.176 × 0.762 (if female) × 1.180 (if black) × (BUN)-0.170 × (Alb)0.318

aMDRD

186 × (Scr)-1.154 × (Age)-0.203 × 0.742 (if female) × 1.212 (if black)

re-aMDRD

175 × (Scr)-1.154 × (Age)-0.203 × 0.742 (if female) × 1.212(if black)

CKD-EPIcr

 Female; Scr ≤ 0.7 mg/dl

144 × (Scr/0.7)−0.329 × 0.993Age [×1.159 if black]

 Female; Scr > 0.7 mg/dl

144 × (Scr/0.7)−1.209 × 0.993Age [×1.159 if black]

 Male; Scr ≤ 0.9 mg/dl

141 × (Scr/0.9)−0.411 × 0.993Age [×1.159 if black]

 Male; Scr > 0.9 mg/dl

141 × (Scr/0.9)−1.209 × 0.993Age [×1.159 if black]

CKD-EPIcys

 Female or Male; Scys ≤ 0.8 mg/dl

133 × (Scys/0.8)−0.499 × 0.996Age [×0.932 if female]

 Female or Male; Scys > 0.8 mg/dl

133 × (Scys/0.8)−1.328 × 0.996Age [×0.932 if female]

CKD-EPIcr-cys

 Female;

  Scr ≤ 0.7 mg/dl; Scys ≤ 0.8 mg/dl

130 × (Scr/0.7)−0.248 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]

  Scr ≤ 0.7 mg/dl; Scys > 0.8 mg/dl

130 × (Scr/0.7)−0.248 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]

  Scr > 0.7 mg/dl; Scys ≤ 0.8 mg/dl

130 × (Scr/0.7)−0.601 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]

  Scr > 0.7 mg/dl; Scys > 0.8 mg/dl

130 × (Scr/0.7)−0.601 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]

 Male;

  Scr ≤ 0.9 mg/dl; Scys ≤ 0.8 mg/dl

135 × (Scr/0.9)−0.207 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]

  Scr ≤ 0.9 mg/dl; Scys > 0.8 mg/dl

135 × (Scr/0.9)−0.207 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]

  Scr > 0.9 mg/dl; Scys ≤ 0.8 mg/dl

135 × (Scr/0.9)−0.601 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]

  Scr > 0.9 mg/dl; Scys > 0.8 mg/dl

135 × (Scr/0.9)−0.601 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]

Statistical analysis

All statistical analysis were performed in SPSS statistical software, version 19.0 for Windows (SPSS, Chicago, IL, USA). Population characteristics were tested with t test, and all data were presented as means ± SD. Body surface area (BSA) was calculated as follows [19]: BSA = (body weight0.425[in kg] × height0.725[in cm]) × 0.007184. To compare the performance of the equations, Pearson correlation analysis and linear regression were applied to compare the correlation between measured GFR and estimated GFR (Pearson coefficient R was calculated) and bias, precision, and accuracy were also calculated as recommended [20, 21]. Bland-Altman plots were used to study the relation between the GFR and measurement error, we assessed the bias as well as the limits of agreement (calculated as the bias plus or minus 1.96 times of the precision) [22]. We applied area under receiver operating characteristic (ROCAUC) curve to describe the diagnostic efficacy of the equations. Paired t test and McNemar test were respectively used to test the difference in bias and accuracy between the estimated equations. In addition, bias, precisions and accuracies were also analyzed within the stratifications of GFR, gender, and age, in order to assess the influences of these variables in subgroups. The cutoffs used for GFR stratification were <60, 60 to 90, and >90 ml/min/1.73 m2, and for age, it were <45, 45 to 60, and >60 years.

Results

Characteristics of the population

In total, 245 Chinese patients with obstructive nephropathy were included in this study, including 131 males and 114 females with a mean age of 51.61 ± 14.17 years. The average value of the measured GFR was 66.54 ± 23.99 ml/min/1.73 m2. Detailed laboratory measurements and basic characteristics of the study population were presented in Table 2.
Table 2

Characteristics of the study population

Variable

Mean ± SD (n = 245) or n[%]

Male gender (n[%])

131(53.5 %)

Age (years)

51.6 ± 14.2

Weight (kg)

62.0 ± 12.1

Height (cm)

163.9 ± 7.2

BMI (kg/m2)

23.0 ± 3.6

BSA (m2)

1.7 ± 0.2

Serum creatinine (mg/dl)

1.2 ± 1.1

Serum cystatin C (mg/l)

1.4 ± 0.7

Serum urea (mg/dl)

18.0 ± 10.8

Serum albumin (g/dl)

3.7 ± 0.5

Measured GFR (ml/min/1.73 m2)

67 ± 24

BMI (kg/m2) = body weight (kg) / height (m)2

BSA (m2) = body weight (kg)0.425 × height (cm)0.725 × 0.007184

BMI body mass index, BSA body surface area, GFR glomerular filtration rate

Association and agreement between estimated GFR and measured GFR

The overall relationships between measured and estimated GFR values were presented in Fig. 1. All of the six prediction equations correlated well with the measured GFR (p < 0.001) (Fig. 2). The Pearson correlation coefficients (R) varied from 0.681 to 0.720, and CKD-EPIcr-cys equation showed the best correlation (R = 0.720, shown in Table 3). CKD-EPIcr-cys equation also gave the highest accuracy (P < 0.01), the smallest bias (P < 0.01) (Table 4) and the best diagnostic efficiency (ROCAUC = 0.847, p < 0.001, Table 3). Furthermore, description of the agreement between estimated and measured GFR were shown in Fig. 3. CKD-EPIcr-cys equation presented the best agreement with the measured GFR (95%CI [−34.87, 40.83]).
Fig. 1

Correlation between measured GFR (mGFR) and estimated GFR (eGFR) using 6 different prediction equations (univariate linear regression model was used, the solid line represents the regression line)

Fig. 2

Curves of Receiver Operating Characteristics analysis for the diagnostic ability of CKD-EPIcr-cys equation (solid-line curve) versus other 5 equations (dotted-line curves). The values of the area under the curve were listed in Table 3

Table 3

Diagnostic values of the equations

Equation

R

ROCAUC

Sensitivity

7MDRD

0.681

0.816

0.72

aMDRD

0.672

0.802

0.71

re-aMDRD

0.672

0.802

0.71

CKD-EPIcr

0.696

0.816

0.72

CKD-EPIcys

0.675

0.833

0.73

CKD-EPIcr-cys

0.720

0.847

0.74

R: coefficient of relationship with measured GFR

ROCAUC: area under receiver operating characteristic curve

Table 4

Performance of the equations

Equation

Bias

Precision

Accuracy(%)

≤15 %

≤30 %

≤50 %

7MDRD

12.14**

23.33**

34.29**

57.55**

78.37**

aMDRD

14.77**

24.65**

29.80**

53.47**

74.69**

re-aMDRD

9.96**

23.33**

32.65**

60.41**

80.41**

CKD-EPIcr

13.51**

21.58**

30.61**

53.88**

78.78**

CKD-EPIcys

−4.24**

20.32**

38.78**

67.76

88.16

CKD-EPIcr-cys

2.98

19.31

44.49

69.39

87.35

Bias was the mean difference between estimated and measured GFR. Precision was the SD of this difference. Accuracy was the percentage of results deviating by ≤ 15, 30 and 50%from the meaured GFR. ** P < 0.01 versus the CKD-EPIcr-cys equation

Fig. 3

Bland-Altman plots of the estimated and measured GFR. eGFR - mGFR represents the difference between the estimated GFR (eGFR) and the measured GFR (mGFR). A positive difference indicates an overestimation by the equation, whereas a negative difference indicates an underestimation. The solid lines indicate the mean difference; the dashed lines indicate the lines of agreement, calculated as the mean difference ±1.96 SD of this difference

Performance of equations in subgroups

In subgroups stratified by GFR, CKD-EPIcys equation exhibited the highest accuracy (52.69 %) and the smallest bias (0.27) in the group of the lowest GFR, while CKD-EPIcys equation and CKD-EPIcr-cys equation had an equally accuracy in patients with a GFR between 60 and 90 ml/min/1.73 m2. In the group of the highest GFR, CKD-EPIcr-cys equation remained the best, but both of them had larger bias in this group. For subgroups stratified by age, CKD-EPIcys equation had the best performance in the group of the youngest patients, with the highest accuracy (71.64 %) and the lowest bias (−1.24); in the other 2 age groups, CKD-EPIcr-cys equation still did the best. The bias of all the 6 equations was larger in women than in men. For both genders, the highest accuracy was reached by CKD-EPIcr-cys equation. Mean bias and precision for subgroups were presented in Fig. 4, and the values were shown in Table 5. In general, the 3 CKD-EPI equations provided better performance than the 3 MDRD equations, while CKD-EPIcr-cys equation gave the best correlation, the highest accuracy (P < 0.01) and diagnostic efficacy, and also the smallest bias (P < 0.01).
Fig. 4

Comparison of the mean bias and precision over subgroups stratified by gender, age, and measured GFR. The mean bias was calculated as the mean of the differences between the estimated and measured GFR per subgroup, whereas the precision was the SD of this difference

Table 5

Performance of the equations in subgroups

Variable

Subgroup

7MDRD

aMDRD

re-aMDRD

CKD-EPIcr

CKD-EPIcys

CKD-EPIcr-cys

B

P

A(30 %)

B

P

A(30 %)

B

P

A(30 %)

B

P

A(30 %)

B

P

A(30 %)

B

P

A(30 %)

GFR

(ml/min/1.73 m2)

<60

13.83

24.39

40.86

15.20

25.13

39.78

11.82

23.57

43.01

14.88

23.90

37.63

0.27

19.33

52.69

5.49

19.83

51.61

60–90

13.69

19.51

64.86

16.84

21.39

59.46

11.46

20.19

68.47

16.92

18.21

54.95

−2.15

19.45

76.58

5.90

17.64

76.58

>90

4.08

28.73

75.61

8.18

30.63

68.29

1.68

28.91

78.05

1.19

20.60

87.80

−20.11

17.39

78.05

−10.62

16.94

90.24

Age

(year)

<45

17.39

28.23

55.22

18.48

29.66

50.75

12.87

27.96

61.19

19.25

24.86

47.76

−1.24

22.72

71.64

6.92

22.09

64.18

45–60

10.48

21.54

59.29

13.76

23.13

56.64

8.92

21.91

64.60

12.44

20.14

56.64

−4.66

19.96

72.57

2.31

18.00

75.22

>60

9.61

20.04

12.70

12.70

21.28

50.77

8.77

20.39

52.31

9.45

19.39

55.38

−6.60

18.16

55.38

0.07

18.05

64.62

Gender

Male

11.80

23.19

64.12

14.53

24.31

56.49

9.83

22.85

64.12

12.24

20.12

59.45

−4.30

20.33

67.18

2.49

18.47

73.28

Female

12.52

23.59

50.00

15.05

25.13

50.00

10.11

23.96

56.14

14.97

23.15

47.37

−4.17

20.40

68.42

3.54

20.30

64.91

Number of obstructed kidney

Unilateral

15.47

23.16

58.43

18.4

24.19

54.82

13.17

23.01

63.86

16.32

20.21

57.23

−2.74

19.87

72.29

5.29

18.59

74.70

Bilateral

5.14

22.24

55.7

7.15

23.99

50.63

3.22

22.66

53.16

7.61

23.27

46.84

−7.38

21.03

58.23

−1.88

20.00

58.23

Disease duration

≥3 months

11.19

25.75

60.61

13.52

26.83

54.55

8.62

25.48

65.91

16.13

20.43

47.79

−3.13

18.47

73.45

4.65

17.13

70.80

<3 months

13.24

20.2

53.98

16.24

21.73

52.21

11.53

20.54

53.98

11.28

22.36

59.09

−5.19

21.81

62.88

1.55

20.96

68.18

Bias was calculated as the mean difference between estimated and measured GFR. Precision was the SD of this difference. Accuracy (≤30 %) was the percentage of results deviating by 30 % from the measured GFR

Discussion

Periodic monitoring of kidney function by a convenient and accurate method is necessary for early diagnosis of renal disease, individualized treatment and prognosis evaluation in clinical practice [3]. This pragmatic study was performed to compare 6 relatively popular GFR estimation equations in 245 Chinese patients with obstructive nephropathy, in order to test the applicability of the equations to pure obstructive nephropathy. As we expected, all these 6 eGFR equations were validated to estimate glomerular filtration function in obstructive nephropathy patients, and CKD-EPIcr-cys equation was more positively correlated with the 99mTc-DTPA GFR and had higher accuracy, even if there is the difference of pathogenesis, pathological and physiological changes and prognosis between obstructive nephropathy and diffuse renal diseases. Of all the 6 equations, the 3 CKD-EPI equations are generally more accurate than the 3 MDRD equations. Among the 3 MDRD equations, aMDRD equation is simpler to use than 7MDRD equation because it does not require inclusion of serum urea nitrogen and albumin concentration. Exclusion of these variables may also make the equation less susceptible to conditions in which serum urea nitrogen or albumin is strongly influenced by factors other than GFR. However, in our study, aMDRD equation did not perform better than 7MDRD equation. It was probably because of the difference in the serum creatinine measuring assay, which was assayed by the kinetic alkaline picrate in the original study of 7MDRD equation [6]. While in our study, it was measured by Roche enzymatic assay, which was more comparable to isotope dilution mass spectrometry (IDMS) -assigned values [8]. This may also explain the better performance of re-aMDRD equation, because re-aMDRD equation was developed by standardizing serum creatinine levels to an assay traceable to IDMS [8, 23]. The Kidney Disease Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommended use of the 2009 CKD-EPI equation (CKD-EPIcr) instead of the MDRD study equation to estimate GFR from serum creatinine. And they suggest to use the 2012 CKD-EPI equations for GFR estimation (CKD-EPIcys, CKD-EPIcr-cys) [24]. It has already been validated that the 2012 CKD-EPI equations are applicable for Chinese population [25]. And our study results are also consistent with the guideline. There are several possible reasons for the best performance of the CKD-EPIcr-cys equation. Firstly, compared with MDRD equations, development and validation of the 3 CKD-EPI equations were conducted with large databases include participants with diverse clinical characteristics, with or without kidney disease, and across a wide range of measured GFR, thus allowing more general applicability than MDRD equations [9, 10]. Secondly, in the CKD-EPI equations, serum creatinine values are stratified according to gender and different cutoff values. However, in MDRD equations, there is no stratification. Thirdly, in comparison with MDRD, CKD-EPIcr-cys was expected to provide a more accurate estimated GFR, as cystatin C is a better glomerular filtration maker [2628]. However, in our study, the CKD-EPI equation based on cystatin C alone was not more accurate than the creatinine estimates, suggesting that unmeasured and largely unknown non-GFR determinants of cystatin C are similar in magnitude to those of creatinine, which is consistent with the original publication [10]. Nevertheless, in subgroups stratified by age and gender, CKD-EPIcys equation exhibited higher accuracy than CKD-EPIcr equation. Thus, we did confirm the advantage of the cystatin C-based equation at less subject to the effects of age and gender than creatinine-based equations [8]. This study has its limitations. First, because of the retrospective data collection, most measurements of serum creatinine and GFR were not conducted on the same day. The daily changing creatinine and GFR may influence the results to some extent. Second, the measurement of serum cystatin C was not calibrated to standard method as did in the original study. Third, the sample size was relatively small, the validation of the 2012 CKD-EPI equations in pure obstructive nephropathy population can not represent the whole CKD population.

Conclusion

In conclusion, the 3 CKD-EPI equations performed better than the 3 MDRD equations in estimating GFR in Chinese obstructive nephropathy patients; while among the 3 CKD-EPI equations, the CKD-EPI equation based on combined creatinine-cystatin C provided the best estimation of GFR. Our data suggested that the CKD-EPI equation based on combined creatinine-cystatin C should be widely used in general clinical practice to assess kidney function for obstructive nephropathy patients in China.

Abbreviations

99mTc-DTPA: 

99mTc-diethylenetriamine penta-acetate

CKD: 

Chronic kidney disease

CKD-EPI: 

Chronic Kidney Disease Epidemiology Collaboration

EDTA: 

Ethylene diamine tetraacetic acid

eGFR: 

estimated glomerular filtration rate

GFR: 

Glomerular filtration rate

IDMS: 

Isotope dilution mass spectrometry

KIDIGO: 

Kidney disease improving global outcomes

MDRD: 

Modification of diet in renal disease

mGFR: 

measured GFR

ROCAUC

Receiver operating characteristic

Declarations

Acknowledgments

Thanks to Department of Nuclear Medicine, Tongji Hospital, Tongji medical College, Huazhong University of Science and Technology for their kind help.

Funding

This work was supported by the National Natural Science Foundation of China (81370798, 81270770), National Natural Science Foundation of China for Young Scholars (81100485) and Special Projects for prevention and treatment of major diseases by the Ministry of Health of China (201002010–3) and by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State education Ministry (No.[2011]1568).

Availability of supporting data

All the data supporting our findings is contained within the manuscript.

Authors’ contributions

MC, GX, MH, SW and YQ participated in the design of the study, collected data, made the figures, and analyzed and interpreted the data, drafted the manuscript. JX, GP and YZ helped to perform the statistical analysis and drafted the manuscript. YD, SG and YG participated in coordination. All authors have given final approval of the version to be published.

Competing interests

The authors declare that they have no competing interests.

Ethics approval and consent to participate

The study was carried out in accordance with the ethical standards of the Helsinki Declaration and approved by the Institution Review Board of of Huazhong University of Science and Technology, Tongji Hospital. Written informed consent was obtained from each patient before any study-specific investigation was performed.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
(2)
Division of nuclear medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

References

  1. Ferguson MA, Waikar SS. Established and emerging markers of kidney function. Clin Chem. 2012;58:680–9.View ArticlePubMedGoogle Scholar
  2. Murphy DP, Hsu C. Estimating glomerular filtration rate: is it good enough? And is it time to move on? Curr Opin Nephrol Hypertens. 2013;22:310–5.View ArticlePubMedGoogle Scholar
  3. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–83.View ArticlePubMedGoogle Scholar
  4. Stevens LA, Levey AS. Measurement of kidney function. Med Clin North Am. 2005;89:457–73.View ArticlePubMedGoogle Scholar
  5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.View ArticlePubMedGoogle Scholar
  6. Levey AS, Bosch JP, Lewis J, Greene T, Rogers N, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–70.View ArticlePubMedGoogle Scholar
  7. Levey AS, Greene T, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol. 2000;11:155.Google Scholar
  8. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–72.View ArticlePubMedGoogle Scholar
  9. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Klahr S. Obstructive nephropathy. Intern Med. 2000;39:355–61.View ArticlePubMedGoogle Scholar
  12. Rule AD, Bergstralh EJ, Melton LJ, Li X, Weaver AL, et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804–11.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Truong LD, Gaber L, Eknoyan G. Obstructive uropathy. Contrib Nephrol. 2011;169:311–26.View ArticlePubMedGoogle Scholar
  14. Wilson DR. Pathophysiology of obstructive nephropathy. Kidney Int. 1980;18:281–92.View ArticlePubMedGoogle Scholar
  15. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol. 2002;283:F861–75.View ArticlePubMedGoogle Scholar
  16. Praditpornsilpa K, Townamchai N, Chaiwatanarat T, Tiranathanagul K, Katawatin P, et al. The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations. Nephrol Dial Transplant. 2011;26:2780–5.View ArticlePubMedGoogle Scholar
  17. Gates GF. Split renal function testing using Tc-99 m DTPA: a rapid technique for determining differential glomerular filtration. Clin Nucl Med. 1983;8:400–7.View ArticlePubMedGoogle Scholar
  18. Ma YC, Zuo L, Zhang CL, Wang M, Wang RF. Comparison of 99mTc-DTPA renal dynamic imaging with modified MDRD equation for glomerular filtration rate estimation in Chinese patients in different stages of chronic kidney disease. Nephrol Dial Transplant. 2007;22:417–23.View ArticlePubMedGoogle Scholar
  19. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5:303.PubMedGoogle Scholar
  20. Eknoyan G, Levin NW. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.View ArticleGoogle Scholar
  21. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003–9.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Martin Bland J, Altman D. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307–10.View ArticleGoogle Scholar
  23. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.View ArticlePubMedGoogle Scholar
  24. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.View ArticleGoogle Scholar
  25. Kong XL, Ma YC, Chen JH, Luo Q, Yu XQ, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant. 2013;28:641–51.View ArticlePubMedGoogle Scholar
  26. Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int. 2010;79:471–7.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2008;75:652–60.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Vinge E, Lindergård B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999;59:587–92.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement